antibody

alpha 1 Antichymotrypsin / AACT Mouse Monoclonal

FNab00318

100 ug

monoclonal

mouse

nonconjugated

western blot, ELISA, immunohistochemistry

alpha 1 Antichymotrypsin / AACT Mouse Monoclonal

Antibody

Mouse

Monoclonal

Unconjugated

IgG2b

100 ug

Human SerpinA3, also known as Alpha 1-antichymotrypsin (AACT), is a member of the serine protease inhibitor class, and is a plasma alpha globulin glycoprotein which increases in the blood during the inflammatory process. SerpinA3, is also an inhibitor of neutrophil cathepsin G, mast cell chymases and pancreatic chymotrypsin. SerpinA3 is produced primarily in the liver, and is identified as an acute-phase inflammatory protein. SerpinA3 deficiency has been associated with liver disease. SerpinA3 has also been implicated in the pathology of a number of devastating human diseases including chronic obstructive pulmonary disease (COPD), Parkinson’s disease (PD), Alzheimer’s disease (AD), Stroke, Cystic Fibrosis, Cerebral Haemorrhage and Multiple System Atrophy.

A1 Antichymotrypsin antibody, AACT antibody, ACT antibody, Alpha 1 antichymotrypsin antibody, GIG24 antibody, GIG25 antibody, Serpin A3 antibody, SERPINA3 antibody,alpha 1 Antichymotrypsin / AACT Antibody

alpha 1 Antichymotrypsin / AACT antibody: Mouse Monoclonal antibody to alpha 1 Antichymotrypsin / AACT

serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3

Human

≥95% as determined by SDS-PAGE

ELISA, WB, IHC

PBS with 0.02% sodium azide and 50% glycerol pH 7.3 , -20℃ for 24 months (Avoid repeated freeze / thaw cycles.)